VOLNEA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Volnea, and what generic alternatives are available?
Volnea is a drug marketed by Xiromed and is included in one NDA.
The generic ingredient in VOLNEA is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Volnea
A generic version of VOLNEA was approved as desogestrel; ethinyl estradiol by DURAMED PHARMS BARR on August 12th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VOLNEA?
- What are the global sales for VOLNEA?
- What is Average Wholesale Price for VOLNEA?
Summary for VOLNEA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Drug Prices: | Drug price information for VOLNEA |
DailyMed Link: | VOLNEA at DailyMed |
US Patents and Regulatory Information for VOLNEA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xiromed | VOLNEA | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 202689-001 | Sep 9, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |